Catalyst Wire Dossier Catalyst Wire Dossier

MRKAd5 HIV-1 Gag Vaccine

Adenovirus 5 vector-based HIV-1 Gag vaccine · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRKAd5 HIV-1 Gag Vaccine, covering 2015-05-28 to 2015-05-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019) [Phase 1]

See pricing